5.72
3.21%
-0.19
전일 마감가:
$5.91
열려 있는:
$5.13
하루 거래량:
410.58K
Relative Volume:
1.49
시가총액:
$11.76M
수익:
-
순이익/손실:
$-16.31M
주가수익비율:
-10.59
EPS:
-0.54
순현금흐름:
$-7.46M
1주 성능:
+56.97%
1개월 성능:
+20.01%
6개월 성능:
+3.55%
1년 성능:
-62.86%
Coeptis Therapeutics Holdings Inc Stock (COEP) Company Profile
명칭
Coeptis Therapeutics Holdings Inc
전화
724-934-6467
주소
105 BRADFORD ROAD, SUITE 420, WEXFORD
COEP을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
COEP
COEPTIS THERAPEUTICS INC
|
0.415 | 2.70M | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
0.29 | 612.00M | 2.07B | -1.42B | -1.37B | -0.6765 |
GOODO
Gladstone Commercial Corporation
|
20.65 | 372.90M | 0 | 0 | 0 | 0.00 |
MOBBW
Mobilicom Limited Warrants
|
0.82 | 278.60M | 0 | 0 | 0 | 0.00 |
SHMD
Schmid Group N V
|
3.01 | 129.62M | 0 | 0 | 0 | 0.00 |
JUNE
Dhandho Junoon Etf
|
3.65 | 47.48M | 0 | 0 | 0 | 0.00 |
Coeptis Therapeutics Holdings Inc 주식(COEP)의 최신 뉴스
Coeptis Therapeutics Holdings Inc (NASDAQ: COEP): Getting A Free Pass? - Stocks Register
Stock market today: Heartcore Enterprises -20.07%, Caravelle International -16.63% among biggest losers in early trading - Business Upturn
Coeptis Therapeutics (COEP) Stock Gains Pre-Hour Traction - Stocks Telegraph
Coeptis Therapeutics Announces Phase 1 Data on DVX201 for COVID-19 Treatment Has Been Accepted for Publication in Molecular Therapy Methods and Clinical Development - Marketscreener.com
Coeptis Therapeutics Holdings, Inc. Adds Autoimmune Indications to Exclusive License Agreement with University of Pittsburgh for SNAP-CAR T and SNAP-CAR NK - Marketscreener.com
Coeptis Therapeutics Holdings, Inc. signed a binding Letter of Intent to acquire NexGenAI Affiliates Network from NexGenAI Solutions Group, Inc. - Marketscreener.com
PHLX Swiss Franc (XDS) QuotePress Release - The Globe and Mail
S&P 500 Growth (IGX) QuotePress Release - The Globe and Mail
Nasdaq Biotechnology Index (NBI) QuotePress Release - The Globe and Mail
S&P 500 Health Care [Sector] (SRHC) QuotePress Release - The Globe and Mail
S&P 500 Consumer Discretionary [Sector] (SRCD) QuotePress Release - The Globe and Mail
KBW Property & Casualty Index (KPX) QuotePress Release - The Globe and Mail
Trading Halt Occurred During This Micro Cap's EOY Surge - MSN
Midday Market Movers: Biggest Stock Declines of the Day – Stock Market - HPBL
Stock market news: Coeptis Therapeutics Holdings -96.03%, OptiNose -93.07% among biggest losers during mid day trading - Business Upturn
Stock market news: Coeptis Therapeutics Holdings declined by 96.03% whereas Baird Medical Investment Holdings +496.89% during mid day trading - Business Upturn
Stock market today: Coeptis Therapeutics Holdings -95.79%, OptiNose -93.64% among biggest losers in early trading - Business Upturn
Stock market today: Coeptis Therapeutics Holdings plunged by 95.98% whereas Baird Medical Investment Holdings gained over 201.90% in early trading - Business Upturn
Coeptis Therapeutics announces reverse stock split - MSN
Coeptis Therapeutics announces reverse stock split plan to remain on the Nasdaq - The Business Journals
Why Is Coeptis Therapeutics Stock Falling On Friday? - Yahoo Finance
Coeptis Therapeutics Announced an Acquisition and a New Divison Launch - Martechcube
Coeptis Therapeutics Announces Reverse Stock Split - Lelezard
Coeptis Therapeutics announces 1-for-20 reverse stock split - Investing.com
Coeptis Therapeutics (COEP) Announces 1-for-20 Reverse Stock Split to Maintain Nasdaq Listing - StockTitan
Coeptis expands with AI platform acquisition and new tech division By Investing.com - Investing.com Canada
Coeptis Therapeutics Announces Reverse Stock Split (PR Newswire) - Aktiellt
Coeptis Therapeutics completes acquisition of AI company, launching technology division - The Business Journals
Coeptis Therapeutics Holdings, Inc. completed the acquisition of NexGenAI Affiliates Network from NexGenAI Solutions Group, Inc. - Marketscreener.com
Stock market today: Millennium Group International surged by 318.96% while SciSparc increased by 153.01% in early trading - Business Upturn
Coeptis Therapeutics Makes Bold Strides in Innovation with the Acquisition of NexGenAI Affiliates Network Platform and Launch of Coeptis Technologies - IT News Online
Coeptis expands with AI platform acquisition and new tech division - Investing.com
Coeptis (NASDAQ: COEP) Launches AI Division, Acquires NexGenAI Platform for Biotech Marketing Automation - StockTitan
Coeptis Therapeutics Holdings, Inc. Reports Voting Results from Annual Meeting - Defense World
COEP Stock Plummets to 52-Week Low at $0.15 Amid Market Challenges - Investing.com Canada
Short Interest in Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) Increases By 11.0% - Defense World
Financial Comparison: Coeptis Therapeutics (NASDAQ:COEP) & PharmaCyte Biotech (NASDAQ:PMCB) - Defense World
Coeptis launching technology division with AI and data security-focused acquisitions - The Business Journals
Coeptis Launches New Technology Division - Contract Pharma
Coeptis Therapeutics Unveils New Technology Division: Coeptis Te - GuruFocus.com
Coeptis Therapeutics launches tech division, eyes data security - Investing.com
Coeptis Therapeutics Unveils New Technology Division: Coeptis Technologies - Marketscreener.com
Why DBV Technologies Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket - Benzinga
Coeptis Therapeutics Expands License Agreement with Deverra to Include Pandemic Preparedness, and Emergency Use - The Eastern Progress Online
Coeptis Therapeutics to Acquire NexGenAI for Enhanced AI Tools By Investing.com - Investing.com South Africa
Coeptis Therapeutics Holdings to Acquire NexGenAI Affiliates Network, - citybiz
Coeptis Therapeutics to Acquire NexGenAI for Enhanced AI Tools - Investing.com India
Coeptis Acquires AI-Powered Marketing Platform - Contract Pharma
Coeptis Therapeutics takes steps to acquire NexGenAI Affiliates Network - The Business Journals
Coeptis Therapeutics Executes Binding Letter of Intent to Acquire Ai-powered Marketing Solutions for Biotech, Pharmaceutical and Other Industries - PR Newswire
Could BigBear.ai Become the Next Palantir Technologies? - AOL
Coeptis Therapeutics Holdings Inc (COEP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Coeptis Therapeutics Holdings Inc 주식 (COEP) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
DeSilva Tara | Director |
Jan 12 '24 |
Buy |
0.58 |
2,266 |
1,305 |
32,266 |
Yerace Daniel Alexander | VP of Operations |
Jan 05 '24 |
Buy |
0.69 |
10,850 |
7,486 |
1,071,455 |
Salkind Gene | Director |
Jan 05 '24 |
Buy |
0.69 |
11,600 |
8,004 |
284,056 |
Mehalick David | CEO and President |
Jan 08 '24 |
Buy |
0.66 |
20,004 |
13,263 |
2,782,615 |
Mehalick David | CEO and President |
Jan 05 '24 |
Buy |
0.69 |
5,050 |
3,484 |
2,762,611 |
Cochran Christopher P. | Director |
Jan 05 '24 |
Buy |
0.77 |
7,000 |
5,390 |
37,000 |
자본화:
|
볼륨(24시간):